AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$GMED

Globus Medical: Q3 Earnings Snapshot

Globus Medical Inc. (GMED) reported Q3 profit of $141.2M, or $1.04 per share, beating earnings estimates of $1.20 per share. Revenue was $763.7M, missing forecasts of $793M. The company expects full-year earnings of $4.95-$5.05 per share and revenue of $3.09B.

Original reporting
finance.yahoo.com
Published Nov 5, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Globus Medical: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$GMEDBearishMed
01

Why it matters

Earnings beat on EPS but revenue miss may cause mixed investor reaction; guidance suggests stable outlook.

02

Market read

First reporting of Q3 earnings provides fresh data for traders; mixed signals affect short-term price action.

03

What to watch

Guidance range remains near prior expectations; cost controls may improve margins later.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Globus Medical is a medical device maker focused on orthopedic and spine solutions.

Company-level read

Ticker impact

$GMEDBearishHigh confidence
Context

Globus Medical reported Q3 earnings with EPS beat and revenue miss, plus full-year guidance.

Expected impact

potential downside pressure from revenue miss, offset by upside from EPS beat

Evidence & confidence

First report of earnings numbers; EPS beat is positive, but revenue fell short of estimates and guidance is modest.

Market effects

Sector

Medical device sector may see modest impact as earnings highlight demand pressures.

Regional

U.S. market may see slight pullback in healthcare stocks.

Global

Limited, primarily U.S. investors.

Counterpoint

What could challenge this read

Revenue miss could signal longer-term demand slowdown, suggesting a short bias.

Key entities

  • Company
    Globus Medical Inc.

    Medical device manufacturer reporting Q3 results.

Read at source← All news

StoryGlobus Medical cuts 2026 revenue outlook after mixed third-quarter results

Also covered by

4 outlets

Related articles

$GMEDHighAI 8/10

Why is Globus Medical stock plunging today?

Globus Medical (GMED) stock fell 12.5% to $71.26, a 52-week low, after Q3 2026 revenue missed estimates at $763.7M, down 0.7% YoY. The company cut full-year revenue guidance to $3.09B. Analysts downgraded the stock, citing weak growth outlook and insider selling. The S&P 500 and Nasdaq rose, but GMED underperformed.

investing.com
$GMEDMedAI 8/10

Globus Medical (GMED) Q3 2026 Earnings Call Transcript

Globus Medical (GMED) reported Q3 2026 revenue of $763.7M, down 0.7% YoY. Non-GAAP EPS was $1.23, up 4%. Free cash flow hit a record $225M. U.S. Spine grew 2%, while Nevro declined 26%. The company expects growth from new product launches in 2027, including SCRIPT implants and EIQ suite. Trauma business grew 19%.

finance.yahoo.com
$GMEDMed

Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program

GLOBUS MEDICAL INC (GMED) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program AUDUBON, PA., November 5, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial resu

SEC EDGAR 8-K